S. Cren et al. / Tetrahedron Letters 43 (2002) 2749–2751
2751
3. Conclusion
Example procedure for removal of the Ses group from
2b: Sulfoximine 2b (0.63 mmol), was dissolved in THF
(10 ml) under an inert atmosphere (N2) and TBAF
(1.58 mmol, 1 M solution in THF) was added at rt. The
mixture was then heated to 50°C for 72 h. The reaction
mixture was concentrated and the crude product
purified by column chromatography on silica eluted
with ethyl acetate to give sulfoximine 3 as a colourless
oil (88%). lH (300 MHz, CDCl3) 2.67 (1H, s), 3.11 (3H,
s), 7.51–7.68 (3H, m), 7.98–8.06 (2H, m).
The use of iminoiodane reagents for the sulfoximina-
tion of a range of functionalised sulfoxides proceeds in
moderate to good yield. Iminoidoanes are generally
compatible with a wider range of functionality than
MSH. The subsequent removal of N-protecting groups
from the sulfoximine adducts is limited when the p-
nosyl group is used but has potential to be more
generally applicable in the case of the Ses group. This
opens the way to the synthesis of highly functionalised
sulfoximine-containing compounds.
Acknowledgements
4. Experimental
We are grateful to the University of Birmingham,
EPSRC, AstraZeneca and Pfizer for financial support
and to Professor Dodd for helpful advice regarding the
preparation of the Ses protected iminoiodane reagent.
Example procedure for imination of 1f using Ph–IꢀN–
Ses: Sulfoxide 1f (1.0 equiv.) was dissolved in dry
acetonitrile and CuPF6[CH3CN]4 (0.05 equiv.) was
added under an inert atmosphere (N2). The mixture was
cooled to 0°C and Ph–IꢀN–Ses (1.1 equiv.) was added
portionwise. The mixture was allowed to warm to rt
and stirred for a further 48 h. The solvent was evapo-
rated and the residue dissolved in ethyl acetate and
filtered through a silica plug. The product sulfoximine
was then isolated as a waxy solid (50%) by recrystallisa-
tion from ethyl acetate/hexane mixture. lH (300 MHz,
CDCl3) 0.0 (9H, s, TMS), 1.1 (2H, m, CH2), 2.8 (2H,
m, CH2), 3.1 (2H, m, CH2), 3.6 (3H, s, CH3), 4.85 (2H,
m, CH2), 7.6–8.0 (5H, m, ArH); lC (75 MHz, CDCl3)
−1.8 (TMS), 10.4 (CH2), 27.9 (CH2), 52.5 (CH3), 53.5
(CH2), 53.8 (CH2), 128.5 (Ar), 129.8 (Ar), 134.8 (Ar),
136.1 (q, Ar), 169.7 (CꢀO); m/z (ES) 414.0 ([M+Na]+,
100%); HRMS calcd for C15H25NO5S2SiNa (414.0841),
Found (414.0826).
References
1. Reggelin, M.; Zur, C. Synthesis 2000, 1.
2. Tamura, Y.; Minamikawa, J.; Ikeda, M. Synthesis 1977, 1.
3. Johnson, C. R.; Kirchoff, R. A.; Corkins, H. G. J. Org.
Chem. 1974, 39, 2458.
4. Muller, J. F. K.; Vogt, P. Tetrahedron Lett. 1998, 39, 4805.
5. Bolm, C.; Muniz, K.; Aguilar, N.; Kesselgruber, M.;
Raabe, G. Synthesis 1999, 1251.
6. Dauban, P.; Dodd, R. H. J. Org. Chem. 1999, 64, 5304.
7. Levenson, C. H.; Meyer, R. B., Jr. J. Med. Chem. 1984,
27, 228.
8. Bolm, C.; Moll, G.; Kahmann, J. D. Chem. Eur. J. 2001,
7, 1118.